BILL ANALYSIS                                                                                                                                                                                                    Ó



                                                                      HR 21


                                                                    Page  1





          Date of Hearing:   May 11, 2015


                             ASSEMBLY COMMITTEE ON RULES


                                Richard Gordon, Chair


          HR 21  
          (Burke) - As Introduced April 30, 2015


          SUBJECT:  Lupus Awareness Month. 


          SUMMARY:  Designates May 2015 as Lupus Awareness Month and  
          extends heartfelt wishes to the Lupus Foundations in California  
          for success in their core objectives in the future.   
          Specifically, this resolution makes the following legislative  
          findings:


          1)Systematic lupus erythematosus, commonly known as lupus, is a  
            chronic, complex, and often life-threatening autoimmune  
            disease.

          2)Research estimates that five million people have been  
            diagnosed with lupus or related diseases throughout the world,  
            and approximately 100,000 more are diagnosed every year; and,  
            new studies by the federal Centers for Disease Control and  
            Prevention indicate that lupus may be twice as common as  
            previously believed, effecting 128.7 out of every 100,000  
            women.

          3)Lupus strikes women primarily when they are 15 to 44 years of  
            age, inclusive, and it disproportionately affects people of  
            color.









                                                                      HR 21


                                                                    Page  2





          4)Lupus impacts more than just the life of the patient, it  
            affects the patient's family, friends, coworkers, employers,  
            and community.

          5)Early diagnosis and proper treatments are critical to the  
            improvement of the quality of life and survival rate of lupus  
            sufferers; and, increased public awareness, education, and  
            research are key to winning the battle against lupus.

          FISCAL EFFECT:  None


          REGISTERED SUPPORT / OPPOSITION:




          Support


          GlaxoSmithKline


          Lupus Foundation of Northern California




          Opposition


          None on file




          Analysis Prepared by:Nicole Willis / RLS. / (916) 319-2800










                                                                      HR 21


                                                                    Page  3